In mid 1970s, The International Society of Oncology and Biomarkers (ISOBM) was established. The society was initially known as the International Society of Onco-developmental Biology and Medicine" (ISOBM) as the principle enthusiasm of the founding members was in misusing proteins required in embryonic improvement as tumor markers. In 2010, the Society was renamed to the International Society of Oncology and Biomarkers (otherwise called ISOBM). This adjustment in name mirrored the then more extensive interests of the society members particularly in the ranges of cancer BioMarkers, novel cancer therapeutics and tumor science. At present, the ISOBM is one of chief universal associations with a wide interest for Tumor BioMarkers.
The society sorts out yearly or half-yearly meetings. These meetings concentrate generally on cancer biomarkers, novel disease therapeutics and tumor biology.Read More»